TGFB1 and neoplasm: In the immune-excluded phenotype, transforming growth factor beta (TGF-β) convert the TME into an inhibitory environment by suppressing the activity of anti-tumor immune cells, while simultaneously enhancing the inhibitory function of Tregs, which was considered to be the primary immunosuppressive factor (46, 47).